Kevin M Pantalone

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Diabetes Care 33:1224-9. 2010
  2. doi Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report
    Kevin M Pantalone
    Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Diabetes Technol Ther 15:342-3. 2013
  3. doi Male hypogonadism: more than just a low testosterone
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:717-25. 2012
  4. doi The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
    Kevin M Pantalone
    Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue NA10, Cleveland, OH, 44195, USA
    Acta Diabetol 46:145-54. 2009
  5. doi Approach to a low TSH level: patience is a virtue
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:803-11. 2010
  6. doi Insulin glargine use during pregnancy
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA
    Endocr Pract 17:448-55. 2011

Detail Information

Publications6

  1. pmc The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Diabetes Care 33:1224-9. 2010
    ..The purpose of this study was to assess the relationship of individual sulfonylureas and the risk of overall mortality in a large cohort of patients with type 2 diabetes...
  2. doi Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report
    Kevin M Pantalone
    Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Diabetes Technol Ther 15:342-3. 2013
    ..We describe the effectiveness of liraglutide therapy in a severely insulin-resistant patient with type 2 diabetes mellitus (DM-2) requiring U-500 insulin...
  3. doi Male hypogonadism: more than just a low testosterone
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:717-25. 2012
    ....
  4. doi The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
    Kevin M Pantalone
    Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue NA10, Cleveland, OH, 44195, USA
    Acta Diabetol 46:145-54. 2009
    ..In conclusions, our results did not identify an increased CAD risk with rosiglitazone in clinical practice. However, the results do reinforce a possible increased risk of adverse events in DM2 patients prescribed sulfonylureas...
  5. doi Approach to a low TSH level: patience is a virtue
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:803-11. 2010
    ....
  6. doi Insulin glargine use during pregnancy
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA
    Endocr Pract 17:448-55. 2011
    ..To review the literature regarding the use of insulin glargine during pregnancy, specifically addressing the issues and concerns surrounding mitogenicity, placental transfer, and maternal and fetal safety...